Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $1.99 Million - $3.01 Million
250,000 New
250,000 $2.9 Million
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $1.51 Million - $2.93 Million
-57,213 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $600,736 - $1.63 Million
57,213 New
57,213 $1.51 Million
Q2 2019

Aug 13, 2019

SELL
$5.92 - $7.41 $1.09 Million - $1.36 Million
-183,854 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $817,727 - $889,879
120,254 Added 189.08%
183,854 $1.33 Million
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $253,764 - $497,352
63,600 New
63,600 $464,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $351M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.